reviewTop 1% cited
Oncologic and Reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 Adenocarcinoma: A systematic review
Gynecologic Oncology · 2012 · Vol. 125(2) · pp. 477–482
Camille C. Gunderson✉(Johns Hopkins Hospital)Amanda N. Fader(Johns Hopkins University)Kathryn A. Carson(Johns Hopkins University)Robert E. Bristow(University of California, Irvine Medical Center)
Endometrial and Cervical Cancer TreatmentsOvarian cancer diagnosis and treatmentEstrogen and related hormone effectsMedicineProgestinMedroxyprogesterone acetateEndometrial hyperplasiaEndometrial cancerCarcinomaGynecologyHormonal therapyHyperplasiaAtypical hyperplasia
MeSH terms
AdenocarcinomaAdultEndometrial HyperplasiaFemaleHumansPregnancyPregnancy OutcomeProgestinsEndometrial NeoplasmsTreatment OutcomeAntineoplastic Agents, HormonalFertility Preservation
Citations
459
FWCI
24.97
field-weighted impact
References
70
Percentile
100%
vs. same field & year
Citations per year
References
Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review
Gynecologic Oncology · 2004 · 334 citations
Cancer Statistics, 2009
CA A Cancer Journal for Clinicians · 2009 · 9,714 citations
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
Medical Entomology and Zoology · 2014 · 17,868 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.